Indeed, centrally acting MAGL inhibitors JZL184 and MJN110 attenuated mechanical and cold hypersensitivity in a chemotherapy-induced neuropathy mouse model via cannabinoid CB1 and CB2 receptor-dependent mechanisms45,46. Here, MGLL is linked to neuropathy.